Table 2 The expression levels of stem cell related factors in terms of clinical and pathological characteristics
From: Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer
Items | No of cases | C-MYC | LIN28 | KLF4 | SOX2 | OCT4 | NANOG | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|  |  | ↑ | ↓ | ↑ | ↓ | ↑ | ↓ | ↑ | ↓ | ↑ | ↓ | ↑ | ↓ |
Gender | |||||||||||||
Male | 18 | 11 | 7 | 11 | 7 | 3 | 15 | 2 | 16 | 3 | 15 | 1 | 17 |
Female | 12 | 11 | 1 | 4 | 8 | 2 | 10 | 0 | 12 | 1 | 11 | 0 | 12 |
Age (years) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≤65 | 22 | 17 | 5 | 12 | 10 | 4 | 18 | 2 | 20 | 4 | 18 | 1 | 21 |
>65 | 8 | 5 | 3 | 3 | 5 | 1 | 7 | 0 | 8 | 0 | 8 | 0 | 8 |
Tumor size (cm) | |||||||||||||
≤4 | 12 | 9 | 3 | 7 | 5 | 3 | 9 | 1 | 11 | 3 | 9 | 1 | 11 |
>4 | 18 | 13 | 5 | 8 | 10 | 2 | 16 | 1 | 17 | 1 | 17 | 0 | 18 |
cTNM | |||||||||||||
I | 13 | 10 | 3 | 8 | 5 | 2 | 11 | 1 | 12 | 2 | 11 | 1 | 12 |
II | 13 | 9 | 4 | 6 | 7 | 2 | 11 | 1 | 12 | 1 | 12 | 0 | 13 |
III | 4 | 3 | 1 | 1 | 3 | 1 | 3 | 0 | 4 | 1 | 3 | 0 | 4 |
Differentiation | |||||||||||||
Well | 6 | 5 | 1 | 3 | 3 | 1 | 5 | 0 | 6 | 0 | 6 | 0 | 6 |
Moderate | 15 | 12 | 3 | 7 | 8 | 3 | 12 | 2 | 13 | 2 | 13 | 1 | 14 |
Poor | 9 | 5 | 4 | 5 | 4 | 1 | 8 | 0 | 9 | 2 | 7 | 0 | 9 |